Evidence map›Paper›PMID 39388058›Full record

SynthesisJournal of epidemiology and global health2024

The Prevalence of Toxoplasma gondii in Saudi Arabia (1994-2023): A Systematic Review and Meta-Analysis.

Hassan N Moafa, Abdullah H Altemani, Ali Alaklabi, Khalid Y Ghailan, Alkhansa Alshabi, Majid Ahmed Darraj, Hammad Ali Fadlalmola

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of epidemiology and global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hassan N MoafaDepartment of Public Health, College of Nursing and Health Sciences, Jazan University, 82912, Jazan, Saudi Arabia. Moafa@jazanu.edu.sa.
Abdullah H AltemaniDepartment of Family and Community Medicine, Faculty of Medicine, University of Tabuk, 47713, Tabuk, Saudi Arabia.
Ali AlaklabiKing Saud Bin Abdulaziz University for Health Science, 11426, Riyadh, Saudi Arabia.
Khalid Y GhailanDepartment of Public Health, College of Nursing and Health Sciences, Jazan University, 82912, Jazan, Saudi Arabia.
Alkhansa AlshabiDepartment of Medical Laboratory Technology, College of Nursing and Health Science, Jazan University, 82911, Jazan, Saudi Arabia.
Majid Ahmed DarrajDepartment of Internal Medicine, College of Medicine, Jazan University, 82913, Jazan, Saudi Arabia.
Hammad Ali FadlalmolaNursing College, Taibah University, 42353, Madinah, Saudi Arabia.

Funding

Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia ISP-2024
6 · The paper itself

Abstract

Toxoplasmosis is one of the most common parasites affecting humans in diverse populations caused by T. gondii. This study aims to systematically review and analyze the prevalence of T. gondii infection among various population categories in Saudi Arabia. Our search was done in five databases: PubMed, Scopus, Cochrane Library, Embase, and Web of Science to find the relevant studies from inception to November 2023. The pooled prevalence of toxoplasmosis among the total population living in Saudi Arabia was estimated using a random-effect meta-analysis approach, and Comprehensive Meta-Analysis software was utilized for this analysis. Our study included 30 case-control and retrospective studies published from 1994 to 2023 involving 20,699 patients from different regions in the Kingdom of Saudi Arabia. Various cities were included, such as Al-Ahsa, Najran, Riyadh, Arar, Mecca, al Khobar, Mushait, Tabuk, jazan, Hail City, Almadinah Almunawwarah, AL-Ahsa, and Abha; 27 reported outcomes related to IgG seroprevalence, revealing an overall toxoplasmosis prevalence of 27.5% in Saudi Arabia. Fifteen studies that measured IgM seroprevalence found an overall toxoplasmosis prevalence of 2.2%. Specifically for pregnant women, IgG seroprevalence was 28%. Among different age categories, the highest toxoplasmosis prevalence was observed in the group aged 31-45 years, reaching 32.5%, while the lowest prevalence was in the 10-20 years category at 19.3%. Regarding gravidity, the grand multi-gravida group exhibited the highest prevalence at 32.9%, with an upper limit of 47.8%. Furthermore, individuals who consumed freshwater demonstrated a higher incidence than those drinking bottled water, with respective prevalence rates of 33.5% and 29.4%. In conclusion, the prevalence of toxoplasmosis in Saudi Arabia is lower than the global average, with significant variations across different age groups, water sources, and dietary habits. Targeted educational programs and public health interventions are essential to raise awareness and reduce the risk of T. gondii infection. Future research should focus on improving study quality and exploring the broader implications of toxoplasmosis on public health in Saudi Arabia.

Indexed as

ToxoplasmaToxoplasmosisHumansPrevalenceSaudi ArabiaSeroepidemiologic StudiesEpidemiologyPrevalenceToxoplasma gondiiToxoplasmosis

Identifiers

PMID39388058
PMCPMC11652434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.